Canada markets closed

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.42-1.40 (-3.80%)
At close: 4:00PM EDT
35.24 -0.18 (-0.51%)
After hours: 04:35PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 54.97B
Enterprise Value 34.55B
Trailing P/E N/A
Forward P/E 1-21.60
PEG Ratio (5 yr expected) 1-5.75
Price/Sales (ttm)42.88
Price/Book (mrq)6.83
Enterprise Value/Revenue 339.27
Enterprise Value/EBITDA 7-30.28

Trading Information

Stock Price History

Beta (5Y Monthly) 0.27
52-Week Change 3-1.68%
S&P500 52-Week Change 337.41%
52 Week High 371.25
52 Week Low 330.41
50-Day Moving Average 338.48
200-Day Moving Average 344.99

Share Statistics

Avg Vol (3 month) 3804.67k
Avg Vol (10 day) 3512.22k
Shares Outstanding 5140.31M
Implied Shares Outstanding 6N/A
Float 91.44M
% Held by Insiders 11.32%
% Held by Institutions 183.54%
Shares Short (Jul. 14, 2021) 44.57M
Short Ratio (Jul. 14, 2021) 46.7
Short % of Float (Jul. 14, 2021) 44.20%
Short % of Shares Outstanding (Jul. 14, 2021) 43.25%
Shares Short (prior month Jun. 14, 2021) 44.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin -134.12%
Operating Margin (ttm)-137.58%

Management Effectiveness

Return on Assets (ttm)-10.24%
Return on Equity (ttm)-24.34%

Income Statement

Revenue (ttm)115.91M
Revenue Per Share (ttm)0.86
Quarterly Revenue Growth (yoy)83.80%
Gross Profit (ttm)-40.22M
EBITDA -150.31M
Net Income Avi to Common (ttm)-155.47M
Diluted EPS (ttm)-1.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)714.26M
Total Cash Per Share (mrq)5.09
Total Debt (mrq)99.56M
Total Debt/Equity (mrq)13.72
Current Ratio (mrq)7.16
Book Value Per Share (mrq)5.19

Cash Flow Statement

Operating Cash Flow (ttm)-176.32M
Levered Free Cash Flow (ttm)-88.83M